Clinical characteristics of prostate cancer in Japanese men in the eras before and after serum prostate-specific antigen testing

International Journal of Urology

Volumn 12, Issue 7, 2005, Pages 662-667

  Okihara, Koji ^a   Nakanishi, Hiroyuki ^a   Nakamura, Terukazu ^a   Mizutani, Yoichi ^a   Kawauchi, Akihiro ^a   Miki, Tsuneharu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Detection; Epidemiology; Prostate; Prostate specific antigen; Prostatic neoplasm

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ANTIGEN DETECTION; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CASTRATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; REVIEW; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; AMERICAS; DIGITAL RECTAL EXAMINATION; EUROPE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEROLOGIC TESTS;

EID: 28444487873     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2005.01113.x     Document Type: Review

References (12)

1. Crawford ED. Epidemiology of prostate cancer. Urology 2003; 62 (Suppl. 6A): 3-12.
2. Hirao Y, Cho M. Statistical analysis of prostate cancer in Japan. Nippon Rinsho 2002; 60 (Suppl. 11): 53-8.
3. Jewett HJ. The present status of radical prostatectomy for stage A and B prostatic cancer. Urol. Clin. North Am. 1975; 2727-30.
4. Sobin JH, Wittekind C. International Union Against Cancer: TNM Classification of Malignant Tumours, 5th edn. Wiley, New York, 1997.
5. Mettlin C, Lee F, Drago J, Murphy GP. The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer 1991; 67: 2949-58.
6. Babaian RJ, Fritsche HA, Bhadkamkar VA, Johnston DA, Naccarato W, Zhang Z. Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5-4.0 ng/ml. Urology 2000; 56: 1000-1006.
7. Jacobsen SJ, Katusic SK, Bergstralh EJ et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA 1995; 274: 1445-9.
8. Suzuki H, Akakura K, Ueda T et al. Clinical characteristics of prostate cancer in elderly Japanese patients 80 years of age or older. Eur. Urol. 2002; 41: 172-7.
9. Farkas A, Schneider D, Perrotti M, Cummings KB, Ward WS. National trends in the epidemiology of prostate cancer, 1973 to 1994: Evidence for the effectiveness of prostate-specific antigen screening. Urology 1998; 52: 444-9.
10. Arai Y, Egawa S, Tobisu K et al. Radical retropubic prostatectomy: Time trends, morbidity and mortality in Japan. BJU Int. 2000; 85: 287-94.
11. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program public use CD-ROM (1973-1994) Surveillance, Epidemiology, and End Results (SEER) Program public use CD-ROM (1973-1994) [program]. National Cancer Institute, Bethesda, 1997.
12. Katsuoka Y, Azuma H. Significance of surgical treatment of prostate cancer: Problems and measures. Nippon Rinsho 2002; 60: 211-17.